Cargando…
Correction to: Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study
| Autores principales: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198920/ https://www.ncbi.nlm.nih.gov/pubmed/36809405 http://dx.doi.org/10.1007/s00262-023-03396-5 |
| _version_ | 1785044827544485888 |
|---|---|
| author | García-Corbacho, Javier Indacochea, Alberto González Navarro, Azucena E. Victoria, Iván Moreno, Débora Pesántez, David Angelats, Laura Modrego-Sanchez, Andrea Sanfeliu, Esther Castillo, Oleguer Blasco, Paula Mezquita, Laura Viñolas, Nuria Nogué, Miquel Galván, Patricia Adamo, Barbara Basté, Neus Sauri, Tamara Juan, Manel Prat, Aleix Schettini, Francesco |
| author_facet | García-Corbacho, Javier Indacochea, Alberto González Navarro, Azucena E. Victoria, Iván Moreno, Débora Pesántez, David Angelats, Laura Modrego-Sanchez, Andrea Sanfeliu, Esther Castillo, Oleguer Blasco, Paula Mezquita, Laura Viñolas, Nuria Nogué, Miquel Galván, Patricia Adamo, Barbara Basté, Neus Sauri, Tamara Juan, Manel Prat, Aleix Schettini, Francesco |
| author_sort | García-Corbacho, Javier |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10198920 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101989202023-05-21 Correction to: Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study García-Corbacho, Javier Indacochea, Alberto González Navarro, Azucena E. Victoria, Iván Moreno, Débora Pesántez, David Angelats, Laura Modrego-Sanchez, Andrea Sanfeliu, Esther Castillo, Oleguer Blasco, Paula Mezquita, Laura Viñolas, Nuria Nogué, Miquel Galván, Patricia Adamo, Barbara Basté, Neus Sauri, Tamara Juan, Manel Prat, Aleix Schettini, Francesco Cancer Immunol Immunother Correction Springer Berlin Heidelberg 2023-02-21 2023 /pmc/articles/PMC10198920/ /pubmed/36809405 http://dx.doi.org/10.1007/s00262-023-03396-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction García-Corbacho, Javier Indacochea, Alberto González Navarro, Azucena E. Victoria, Iván Moreno, Débora Pesántez, David Angelats, Laura Modrego-Sanchez, Andrea Sanfeliu, Esther Castillo, Oleguer Blasco, Paula Mezquita, Laura Viñolas, Nuria Nogué, Miquel Galván, Patricia Adamo, Barbara Basté, Neus Sauri, Tamara Juan, Manel Prat, Aleix Schettini, Francesco Correction to: Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study |
| title | Correction to: Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study |
| title_full | Correction to: Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study |
| title_fullStr | Correction to: Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study |
| title_full_unstemmed | Correction to: Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study |
| title_short | Correction to: Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study |
| title_sort | correction to: determinants of activity and efficacy of anti-pd1/pd-l1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198920/ https://www.ncbi.nlm.nih.gov/pubmed/36809405 http://dx.doi.org/10.1007/s00262-023-03396-5 |
| work_keys_str_mv | AT garciacorbachojavier correctiontodeterminantsofactivityandefficacyofantipd1pdl1therapyinpatientswithadvancedsolidtumorsrecruitedinaclinicaltrialsunitalongitudinalprospectivebiomarkerbasedstudy AT indacocheaalberto correctiontodeterminantsofactivityandefficacyofantipd1pdl1therapyinpatientswithadvancedsolidtumorsrecruitedinaclinicaltrialsunitalongitudinalprospectivebiomarkerbasedstudy AT gonzaleznavarroazucenae correctiontodeterminantsofactivityandefficacyofantipd1pdl1therapyinpatientswithadvancedsolidtumorsrecruitedinaclinicaltrialsunitalongitudinalprospectivebiomarkerbasedstudy AT victoriaivan correctiontodeterminantsofactivityandefficacyofantipd1pdl1therapyinpatientswithadvancedsolidtumorsrecruitedinaclinicaltrialsunitalongitudinalprospectivebiomarkerbasedstudy AT morenodebora correctiontodeterminantsofactivityandefficacyofantipd1pdl1therapyinpatientswithadvancedsolidtumorsrecruitedinaclinicaltrialsunitalongitudinalprospectivebiomarkerbasedstudy AT pesantezdavid correctiontodeterminantsofactivityandefficacyofantipd1pdl1therapyinpatientswithadvancedsolidtumorsrecruitedinaclinicaltrialsunitalongitudinalprospectivebiomarkerbasedstudy AT angelatslaura correctiontodeterminantsofactivityandefficacyofantipd1pdl1therapyinpatientswithadvancedsolidtumorsrecruitedinaclinicaltrialsunitalongitudinalprospectivebiomarkerbasedstudy AT modregosanchezandrea correctiontodeterminantsofactivityandefficacyofantipd1pdl1therapyinpatientswithadvancedsolidtumorsrecruitedinaclinicaltrialsunitalongitudinalprospectivebiomarkerbasedstudy AT sanfeliuesther correctiontodeterminantsofactivityandefficacyofantipd1pdl1therapyinpatientswithadvancedsolidtumorsrecruitedinaclinicaltrialsunitalongitudinalprospectivebiomarkerbasedstudy AT castillooleguer correctiontodeterminantsofactivityandefficacyofantipd1pdl1therapyinpatientswithadvancedsolidtumorsrecruitedinaclinicaltrialsunitalongitudinalprospectivebiomarkerbasedstudy AT blascopaula correctiontodeterminantsofactivityandefficacyofantipd1pdl1therapyinpatientswithadvancedsolidtumorsrecruitedinaclinicaltrialsunitalongitudinalprospectivebiomarkerbasedstudy AT mezquitalaura correctiontodeterminantsofactivityandefficacyofantipd1pdl1therapyinpatientswithadvancedsolidtumorsrecruitedinaclinicaltrialsunitalongitudinalprospectivebiomarkerbasedstudy AT vinolasnuria correctiontodeterminantsofactivityandefficacyofantipd1pdl1therapyinpatientswithadvancedsolidtumorsrecruitedinaclinicaltrialsunitalongitudinalprospectivebiomarkerbasedstudy AT noguemiquel correctiontodeterminantsofactivityandefficacyofantipd1pdl1therapyinpatientswithadvancedsolidtumorsrecruitedinaclinicaltrialsunitalongitudinalprospectivebiomarkerbasedstudy AT galvanpatricia correctiontodeterminantsofactivityandefficacyofantipd1pdl1therapyinpatientswithadvancedsolidtumorsrecruitedinaclinicaltrialsunitalongitudinalprospectivebiomarkerbasedstudy AT adamobarbara correctiontodeterminantsofactivityandefficacyofantipd1pdl1therapyinpatientswithadvancedsolidtumorsrecruitedinaclinicaltrialsunitalongitudinalprospectivebiomarkerbasedstudy AT basteneus correctiontodeterminantsofactivityandefficacyofantipd1pdl1therapyinpatientswithadvancedsolidtumorsrecruitedinaclinicaltrialsunitalongitudinalprospectivebiomarkerbasedstudy AT sauritamara correctiontodeterminantsofactivityandefficacyofantipd1pdl1therapyinpatientswithadvancedsolidtumorsrecruitedinaclinicaltrialsunitalongitudinalprospectivebiomarkerbasedstudy AT juanmanel correctiontodeterminantsofactivityandefficacyofantipd1pdl1therapyinpatientswithadvancedsolidtumorsrecruitedinaclinicaltrialsunitalongitudinalprospectivebiomarkerbasedstudy AT prataleix correctiontodeterminantsofactivityandefficacyofantipd1pdl1therapyinpatientswithadvancedsolidtumorsrecruitedinaclinicaltrialsunitalongitudinalprospectivebiomarkerbasedstudy AT schettinifrancesco correctiontodeterminantsofactivityandefficacyofantipd1pdl1therapyinpatientswithadvancedsolidtumorsrecruitedinaclinicaltrialsunitalongitudinalprospectivebiomarkerbasedstudy |